How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AR

NASDAQ:ARWR
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AR

Arrowhead Pharmaceuticals IncNASDAQ ARWR Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is ARWR undervalued compared to its fair value?

The fair value of ARWR stock is hidden USD. Relative to the market price of 27.62 USD Arrowhead Pharmaceuticals Inc is hidden.

Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company uses a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Com...[More about valuation]

Arrowhead Pharmaceuticals Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

3.669 $B

Price:

27.62 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-1.016

FINANCIALS

Arrowhead Pharmaceuticals financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.13 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.13 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.96 B
0.48 B

Financial Position Analysis

Assets

0.96 B
Current Assets
0.54 B
Total non-current assets
0.41 B

Total current liabilities
0.065 B
Total non-current liabilities
0.41 B

Cash Flow Statement

-0.13 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.092 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Arrowhead Pharmaceuticals fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-147 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-147 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-60 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ARWR attractive for investment based on fundamental analysis?

ARWR stock rating is hidden. Arrowhead Pharmaceuticals is a hidden by Eyestock methodology.

Get ARWR Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-1 328

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

5.481

Debt / Equity ratio:

0.205

ROE:

-147

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ARWR analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ARWR to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Arrowhead Pharmaceuticals Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Arrowhead Pharmaceuticals Inc dividends

ARWR dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ARWR stock

About the company Arrowhead Pharmaceuticals Inc

Market cap $B

3.669

Dividend yield

Shares outstanding

108.31 B

Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company uses a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. The Company is focused on developing drugs for diseases with a genetic basis, characterized by the overproduction of one or more proteins. The Company's pipeline includes ARO-APOC3 for hypertriglyceridemia, ARO-ANG3 for dyslipidemia, ARO-ENaC2 for cystic fibrosis, ARO-DUX4 for facioscapulohumeral muscular dystrophy, ARO-COV for the coronavirus that causes COVID-19 and other possible future pulmonary-borne pathogens, ARO-C3 for complement mediated diseases, ARO-RAGE and ARO-MUC5AC for various muco-obstructive or inflammatory pulmonary conditions and ARO-MMP7 for idiopathic pulmonary fibrosis.

ARWR profile

  • Ticker

    ARWR

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    14 December 1993

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    397

  • City

    Pasadena

  • Address

    177 E Colorado Blvd, Suite 700

  • Cusip

    04280A100